- AHIP's uplifting presentation on the value of employer sponsored health care
- AHIP's helpful presentation on its initiative to address the opioid crisis.
- Healthcare Dive's report on CVS Health's 4th Quarter 2017 earnings. "CEO Larry Merlo said on the company's Q4 earnings call that 'nothing that has surfaced' has come as a surprise, adding that he still expects the deal to close in the second half of 2018," and
- CNBC's report on Gilead's 4th Quarter 2017 earnings. Gilead is the company that first brought the Hepatitis C cures to market at an astoundingly high price. Those glory days are over due to competition and the success of the drug.
Thursday, February 08, 2018
While we wait to see whether Congress can reach a budget agreement overnight, here are two AHIP PowerPoints and two earning reports to ponder: